ANI Pharmaceuticals, Inc. (BST:BSFA)
Germany · Delayed Price · Currency is EUR 63.00
-2.00 (-3.08%)
At close: Feb 27, 2026
ANI Pharmaceuticals Cash Flow Statement
Financials in millions USD. Fiscal year is January - December.
Millions USD. Fiscal year is Jan - Dec.
Fiscal Year | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|
Period Ending | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 |
Net Income | 78.34 | -18.52 | 18.78 | -47.9 | -42.6 |
Depreciation & Amortization | 91.42 | 67.73 | 59.79 | 59.65 | 47.25 |
Loss (Gain) From Sale of Assets | 0.38 | -5.35 | - | -0.75 | -1.82 |
Asset Writedown & Restructuring Costs | 0.77 | 7.6 | - | 1.73 | 2.37 |
Loss (Gain) From Sale of Investments | -2.82 | -6.31 | - | - | - |
Stock-Based Compensation | 37.93 | 29.34 | 20.65 | 14.6 | 10.49 |
Other Operating Activities | -13.66 | 0.7 | -5.12 | -7.23 | -12.28 |
Change in Accounts Receivable | -58.53 | -21.09 | 3.36 | -36.91 | -5.55 |
Change in Inventory | -5.96 | -21.29 | -5.84 | -23.63 | 3.22 |
Change in Accounts Payable | 15.16 | 0.48 | 7.55 | 5.04 | 10.17 |
Change in Income Taxes | -15.53 | -1.42 | 11.99 | -0.16 | -7.57 |
Change in Other Net Operating Assets | 57.74 | 32.13 | 7.8 | 4.36 | -0.35 |
Operating Cash Flow | 185.23 | 64.02 | 118.96 | -31.2 | 3.32 |
Operating Cash Flow Growth | 189.34% | -46.19% | - | - | -78.24% |
Capital Expenditures | -13.84 | -16.24 | -8.87 | -8.88 | -2.56 |
Sale of Property, Plant & Equipment | - | 13.51 | - | 0.75 | 2.65 |
Cash Acquisitions | - | -401.28 | - | -0.03 | -84.49 |
Sale (Purchase) of Intangibles | -20.49 | -0.72 | -9.64 | -7.58 | -21.08 |
Investing Cash Flow | -34.32 | -404.72 | -18.51 | -15.74 | -105.48 |
Long-Term Debt Issued | - | 641.25 | - | - | 310.03 |
Long-Term Debt Repaid | -10.16 | -296.03 | -3 | -3 | -211.01 |
Total Debt Repaid | -10.16 | -296.03 | -3 | -3 | -211.01 |
Net Debt Issued (Repaid) | -10.16 | 345.22 | -3 | -3 | 99.02 |
Issuance of Common Stock | 13.6 | 6.49 | 89.55 | 1.46 | 71.65 |
Repurchase of Common Stock | -12.21 | -10.96 | -4.99 | -1.96 | -0.89 |
Preferred Dividends Paid | -1.16 | -1.63 | -1.63 | -1.63 | -0.19 |
Dividends Paid | -1.16 | -1.63 | -1.63 | -1.63 | -0.19 |
Other Financing Activities | -0.03 | -74.18 | -12.5 | - | - |
Financing Cash Flow | -9.94 | 264.95 | 67.44 | -5.13 | 194.6 |
Foreign Exchange Rate Adjustments | -0.23 | -0.47 | - | - | - |
Net Cash Flow | 140.73 | -76.23 | 167.89 | -52.07 | 92.43 |
Free Cash Flow | 171.39 | 47.78 | 110.09 | -40.08 | 0.77 |
Free Cash Flow Growth | 258.70% | -56.60% | - | - | -91.62% |
Free Cash Flow Margin | 19.40% | 7.78% | 22.61% | -12.67% | 0.35% |
Free Cash Flow Per Share | 8.07 | 2.47 | 6.05 | -2.46 | 0.06 |
Cash Interest Paid | - | 24.38 | 31.43 | 21.48 | 9.71 |
Cash Income Tax Paid | - | 19.06 | 1.23 | 0.29 | 10.37 |
Levered Free Cash Flow | 91.82 | 28.57 | 114.36 | -38.7 | -28.62 |
Unlevered Free Cash Flow | 104.35 | 49.28 | 136.26 | -20.94 | -21.16 |
Change in Working Capital | -7.12 | -11.19 | 24.86 | -51.3 | -0.08 |
Source: S&P Global Market Intelligence. Standard template. Financial Sources.